HONG KONG, Jan. 31, 2023 /PRNewswire/ -- In response to the infection peak season of COVID-19 in rural areas that may be brought about by people returning home during Chinese New Year, Fosun ...

A large-scale study reveals azvudine’s comparable efficacy to Paxlovid, fewer adverse effects, and potential antitumor benefits in patients with liver cancer. Study: Real‐world effectiveness and ...

This new article publication from Acta Pharmaceutica Sinica B, discusses a retrospective cohort study of the efficacy and safety of oral azvudine versus nirmatrelvir/ritonavir in elderly hospitalized ...

HONG KONG, Jan. 20, 2023 /PRNewswire/ -- On January 16, the second stage of "A Healthy Winter Action" initiated by Fosun Foundation in conjunction with other institutions kicked off, with 19,600 ...

Genuine Biotech Co. Ltd.’s azvudine has been granted conditional approval by China’s NMPA for the treatment of COVID-19. The drug, first granted conditional approval from the NMPA to treat ...

As Omicron, a fast-spreading variant of the virus behind COVID-19 started to sweep the world in late 2021, doctors and researchers at China’s Beijing Chao-Yang Hospital braced themselves for the ...